A 24-week randomized, double-blind, placebo-controlled study of the efficacy and tolerability of TNFR: Fc (etanercept) in the treatment of dementia of the Alzheimer type

被引：0
|
作者：
Bohac, D [1 ]
Burke, W [1 ]
Cotter, R [1 ]
Zheng, J [1 ]
Potter, J [1 ]
机构：
[1] Howard Gendelman Univ Nebraska, Med Ctr, Omaha, NE USA
来源：
NEUROBIOLOGY OF AGING | 2002年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
315
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [1] Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
    Ringman, John M.
    Frautschy, Sally A.
    Teng, Edmond
    Begum, Aynun N.
    Bardens, Jenny
    Beigi, Maryam
    Gylys, Karen H.
    Badmaev, Vladimir
    Heath, Dennis D.
    Apostolova, Liana G.
    Porter, Verna
    Vanek, Zeba
    Marshall, Gad A.
    Hellemann, Gerhard
    Sugar, Catherine
    Masterman, Donna L.
    Montine, Thomas J.
    Cummings, Jeffrey L.
    Cole, Greg M.
    ALZHEIMERS RESEARCH & THERAPY, 2012, 4 (05)
  • [2] Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
    John M Ringman
    Sally A Frautschy
    Edmond Teng
    Aynun N Begum
    Jenny Bardens
    Maryam Beigi
    Karen H Gylys
    Vladimir Badmaev
    Dennis D Heath
    Liana G Apostolova
    Verna Porter
    Zeba Vanek
    Gad A Marshall
    Gerhard Hellemann
    Catherine Sugar
    Donna L Masterman
    Thomas J Montine
    Jeffrey L Cummings
    Greg M Cole
    Alzheimer's Research & Therapy, 4
  • [3] A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer's Disease
    Nakamura, Yu
    Imai, Yukimichi
    Shigeta, Masahiro
    Graf, Ana
    Shirahase, Toru
    Kim, Hyosung
    Fujii, Akifumi
    Mori, Joji
    Homma, Akira
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 163 - 179
  • [4] EFFICACY, SAFETY AND TOLERABILITY OF BREXPIPRAZOLE FOR THE TREATMENT OF AGITATION IN ALZHEIMER'S DEMENTIA: A 12-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Grossberg, George
    Lee, Daniel
    Slomkowski, Mary
    Hefting, Nanco
    Chen, Dalei
    Larsen, Groes
    Kohegyi, Eva
    Hobart, Mary
    Cummings, Jeffrey
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2023, 31 (03): : S99 - S100
  • [5] Atherosclerotic cardiovascular risk assessment in a 24-week, randomized, double-blind, placebo-controlled study of aldafermin
    Gunn, Nadege T.
    Ling, Lei
    Neff, Guy
    Guy, Cynthia
    Bashir, Mustafa
    Paredes, Angelo
    Frias, Juan
    Younes, Ziad H.
    Trotter, James F.
    Moussa, Sam
    Kohli, Anita
    Connelly, Margery A.
    Nelson, Kristen
    Gottwald, Mildred
    Chang, William
    Yan, Andrew
    DePaoli, Alex
    Lieu, Hsiao
    Harrison, Stephen
    JOURNAL OF HEPATOLOGY, 2021, 75 : S617 - S617
  • [6] Effects of Varenicline in Adult Smokers: A Multinational, 24-Week, Randomized, Double-Blind, Placebo-Controlled Study
    Bolliger, Chris T.
    Issa, Jaqueline S.
    Posadas-Valay, Rodolfo
    Safwat, Tarek
    Abreu, Paula
    Correia, Eurico A.
    Park, Peter W.
    Chopra, Pravin
    CLINICAL THERAPEUTICS, 2011, 33 (04) : 465 - 477
  • [7] Efficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind Study
    Simpson, Richard W.
    Nicholson, Geoffrey C.
    Proietto, Joseph
    Sarah, Alana
    Sanders, Kerrie M.
    Phillips, Gabrielle
    Chambers, Jo
    MacGinley, Rob
    Orford, Neil
    Walder, Ken
    Krippner, Guy
    Skoff, Kathy
    Wacher, Vincent J.
    DIABETES CARE, 2014, 37 (11) : 3121 - 3123
  • [8] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
    Rogers, SL
    Farlow, MR
    Doody, RS
    Mohs, R
    Friedhoff, LT
    Albala, B
    Baumel, B
    Booker, G
    Dexter, J
    Farmer, M
    Feighner, JP
    Ferris, S
    Gordon, B
    Gorman, DG
    Hanna, G
    Harrell, LE
    Hubbard, R
    Kennedy, J
    McCarthy, J
    Scharre, DW
    Schaerf, F
    Schneider, L
    Seltzer, B
    Siegal, A
    Stark, SR
    Strauss, A
    Walshe, TM
    NEUROLOGY, 1998, 50 (01) : 136 - 145
  • [9] Treatment of Major Depressive Disorder Using Botulinum Toxin A: A 24-Week Randomized, Double-Blind, Placebo-Controlled Study
    Magid, Michelle
    Reichenberg, Jason S.
    Poth, Poppy E.
    Robertson, Henry T.
    LaViolette, Amanda K.
    Kruger, Tillmann H. C.
    Wollmer, M. Axel
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (08) : 837 - +
  • [10] Double-blind, randomized, placebo-controlled clinical trial on the efficacy and tolerability of a physostigmine patch in patients with senile dementia of the Alzheimer type
    Möller, HJ
    Hampel, H
    Hegerl, U
    Schmitt, W
    Walter, K
    PHARMACOPSYCHIATRY, 1999, 32 (03) : 99 - 106
12345